If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Retevmo™ (selpercatinib) capsules40 mg, 80 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
To request a sales representative visit, please complete and submit the Sales Representative Request Form.
Date of Last Review: May 14, 2020